Is Kimberly-Clark Stock A Better Pick Over Altria?

+9.79%
Upside
141
Market
155
Trefis
KMB: Kimberly-Clark logo
KMB
Kimberly-Clark

We believe that Kimberly-Clark stock  (NYSE: KMB) is currently a better pick than the tobacco company, Altria stock (NYSE: MO), given its better valuation. The decision to invest often comes down to finding the best stocks within the scope of certain characteristics that suit an investment style. In this case, although these companies are from different industries, they share a similar revenue base of around $20 billion and both are consumer defensive stocks.

Although Kimberly-Clark has seen a better revenue growth, Altria is more profitable. Also, KMB stock trades at 20x forward expected earnings, versus 10x for Altria. We think this gap in valuation will remain in favor of Kimberly-Clark in the coming years. There is more to the comparison, and in the sections below, we discuss why we think KMB will outperform MO in the next three years. We compare a slew of factors, such as historical revenue growth, returns, and valuation.

1. Altria Stock Has Fared Slightly Better Than Kimberly-Clark In The Last Three Years

Relevant Articles
  1. Is Kimberly-Clark Stock Fairly Valued At $135 After A Solid Q1?
  2. Should You Pick Kimberly-Clark Stock At $120 After A Downbeat Q4?
  3. Is Kimberly-Clark Stock Fully Priced At $120?
  4. Which Is A Better Pick – Kimberly-Clark Stock Or IDEXX Laboratories?
  5. Which Is A Better Consumer Defensive Pick – Kimberly-Clark Or CL Stock?
  6. Is Kimberly-Clark Stock A Better Pick Over Its Industry Peer?

KMB stock has shown gains of 20% from levels of $120 in early January 2021 to around $145 now. In comparison, MO stock has shown gains of 25%, while the broader S&P500 has risen 50% over this period. However, the increase in KMB and MO stocks has been far from consistent. Returns for KMB stock were 10% in 2021, -2% in 2022, and -7% in 2023, while that for MO were 16%, -4%, and -12% over these years, respectively. In comparison, returns for the S&P 500 have been 27% in 2021, -19% in 2022, and 24% in 2023 — indicating that KMB and MO underperformed the S&P in 2021 and 2023.

In fact, consistently beating the S&P 500 — in good times and bad — has been difficult over recent years for individual stocks; for heavyweights in the Consumer Staples sector including WMT, PG, and COST, and even for the megacap stars GOOG, TSLA, and MSFT. In contrast, the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has outperformed the S&P 500 each year over the same period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.

2. Kimberly-Clark’s Revenue Growth Is Better

Kimberly-Clark’s revenue growth has been better, with a 2.2% average annual growth rate in the last three years, compared to -0.5% for Altria.

Altria sells its tobacco products in the U.S. markets. Due to supply disruptions, the company’s revenue growth was impacted during the pandemic. Altria also sold its wine business for $1.2 billion in 2021, with an increased focus on smoking and smokeless products. With higher inflation, the company is seeing a decline in cigarette volume lately, a trend expected to continue going forward. For perspective, the volume of smokable products declined 9.6% y-o-y to 86.4 billion sticks in 2022, and another 9.8% to 76.3 billion sticks in 2023. That said, pricing growth is helping the company offset most of the revenue loss from volume. Altria is also benefiting from its relatively new smoke-free products, including NJOY and on!

For Kimberly-Clark, revenue growth is driven by better price realizations. The company produces primarily paper-based consumer products, manufacturing sanitary paper products and surgical & medical instruments. The Personal Care segment made up around 52% of the company’s sales in 2023, contributing $10.7 billion to total revenue. Although the company is benefiting from pricing gains for its products, the volume growth has been tepid lately.

Looking at the last twelve months, both companies have seen a decline of <1%.  Our Altria Revenue Comparison and Kimberly-Clark Revenue Comparison dashboards provide more insight into the companies’ sales.

3. Altria Is More Profitable But Kimberly-Clark Offers Lower Risk

Altria’s reported operating margin expanded from 52.1% in 2020 to 56% in 2023. In comparison, Kimberly-Clark’s operating margin contracted from 16.9% to 14.7% over this period. Looking at the last twelve-month period, Altria’s operating margin of 56.3fares much better than 14.6% for the latter.

Looking at financial risk, Kimberly-Clark fares better. While Altria’s 29% debt as a percentage of equity is higher than 16% for Kimberly-Clark, its 5% cash as a percentage of assets is also slightly lower than 7% for the latter. This implies that Kimberly-Clark has a better debt position and more cash cushion.

4. The Net of It All

We see that Kimberly-Clark has seen better revenue growth and has a better financial position. On the other hand, Altria is more profitable. Now, looking at the prospects, we believe Kimberly-Clark is the better choice of the two. At its current levels, MO stock is trading at 10x forward expected earnings of $5.13 on a per share and adjusted basis in 2024. The 10x figure is slightly higher than the average of 9x seen over the last four years. In comparison, at its current levels of around $145, Kimberly-Clark stock trades at close to 20x expected 2024 earnings of $7.32 per share. This compares with the 21x average P/E multiple for KMB seen over the last four years.
While KMB may outperform MO in the next three years, it is helpful to see how Kimberly-Clark’s Peers fare on metrics that matter. You will find other valuable comparisons for companies across industries at Peer Comparisons.

Returns Aug 2024
MTD [1]
2024
YTD [1]
2017-24
Total [2]
 KMB Return 7% 21% 63%
 MO Return 5% 28% -24%
 S&P 500 Return 1% 17% 150%
 Trefis Reinforced Value Portfolio 5% 12% 732%

[1] Returns as of 8/21/2024
[2] Cumulative total returns since the end of 2016

Invest with Trefis Market-Beating Portfolios
See all Trefis Price Estimates